Close Menu

NEW YORK — MBio Diagnostics said on Monday that it will receive $1.5 million in new funding under a point-of-care immunoassay development contract with the US Defense Advanced Research Projects Agency (DARPA).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.